{"id":"https://openalex.org/W7213277486","doi":"https://doi.org/10.64898/2026.09.10.750598","title":"Replacing In Vivo Experiments for PK/PD Target Determination Through In Vitro Time-Kill Experiments and PK/PD Modelling Incorporating Inter-strain Variability: Application to Meropenem Against Pseudomonas aeruginosa","display_name":"Replacing In Vivo Experiments for PK/PD Target Determination Through In Vitro Time-Kill Experiments and PK/PD Modelling Incorporating Inter-strain Variability: Application to Meropenem Against Pseudomonas aeruginosa","publication_year":2026,"publication_date":"2026-09-15","ids":{"openalex":"https://openalex.org/W7213277486","doi":"https://doi.org/10.64898/2026.09.10.750598"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.10.750598","doi":"https://doi.org/10.64898/2026.09.10.750598","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.10.750598","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/15/2026.09.10.750598.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/15/2026.09.10.750598.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026205487","display_name":"Julien M. Buyck","orcid":"https://orcid.org/0000-0003-0299-4654","observed_orcids":["https://orcid.org/0000-0003-0299-4654"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]},{"id":"https://openalex.org/I4387154066","display_name":"Pharmacologie des anti-infectieux et antibior\u00e9sistance","ror":"https://ror.org/041v99f68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julien M. Buyck","raw_affiliation_strings":["Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France"],"raw_orcid":"https://orcid.org/0000-0003-0299-4654","affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092875370","display_name":"Ombeline Krekounian","orcid":"https://orcid.org/0009-0007-6624-2597","observed_orcids":["https://orcid.org/0009-0007-6624-2597"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]},{"id":"https://openalex.org/I4387154066","display_name":"Pharmacologie des anti-infectieux et antibior\u00e9sistance","ror":"https://ror.org/041v99f68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ombeline Krekounian","raw_affiliation_strings":["Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France"],"raw_orcid":"https://orcid.org/0009-0007-6624-2597","affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148946824","display_name":"Tom Collet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]},{"id":"https://openalex.org/I4387154066","display_name":"Pharmacologie des anti-infectieux et antibior\u00e9sistance","ror":"https://ror.org/041v99f68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Tom Collet","raw_affiliation_strings":["Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036800533","display_name":"Vincent Aranzana\u2010Climent","orcid":"https://orcid.org/0000-0002-1258-8054","observed_orcids":["https://orcid.org/0000-0002-1258-8054"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]},{"id":"https://openalex.org/I4387154066","display_name":"Pharmacologie des anti-infectieux et antibior\u00e9sistance","ror":"https://ror.org/041v99f68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Vincent Aranzana-Climent","raw_affiliation_strings":["Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France"],"raw_orcid":"https://orcid.org/0000-0002-1258-8054","affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051036198","display_name":"Nicolas Gr\u00e9goire","orcid":"https://orcid.org/0000-0001-6436-3757","observed_orcids":["https://orcid.org/0000-0001-6436-3757"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I32881790","display_name":"Universit\u00e9 de Poitiers","ror":"https://ror.org/04xhy8q59","country_code":"FR","type":"education","lineage":["https://openalex.org/I32881790"]},{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]},{"id":"https://openalex.org/I4387154066","display_name":"Pharmacologie des anti-infectieux et antibior\u00e9sistance","ror":"https://ror.org/041v99f68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Gr\u00e9goire","raw_affiliation_strings":["Laboratoire de Toxicologie et de Pharmacocin\u00e9tique, CHU de Poitiers, Poitiers, France","Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France"],"raw_orcid":"https://orcid.org/0000-0001-6436-3757","affiliations":[{"raw_affiliation_string":"Laboratoire de Toxicologie et de Pharmacocin\u00e9tique, CHU de Poitiers, Poitiers, France","institution_ids":["https://openalex.org/I4210111187"]},{"raw_affiliation_string":"Universit\u00e9 de Poitiers, PHAR2, Inserm U1070, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5036800533"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I32881790","https://openalex.org/I4387154066"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-targets","display_name":"pharmacokinetic/pharmacodynamic targets","score":0.7770000100135803},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":0.7739999890327454},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":1.0},{"id":"https://openalex.org/keywords/inter-strain-variability","display_name":"inter-strain variability","score":0.9340000152587891},{"id":"https://openalex.org/keywords/population-pharmacodynamics","display_name":"population pharmacodynamics","score":0.7749999761581421},{"id":"https://openalex.org/keywords/antibiotic-dosing-optimization","display_name":"antibiotic dosing optimization","score":0.7400000095367432},{"id":"https://openalex.org/keywords/clinical-isolates","display_name":"clinical isolates","score":0.746999979019165},{"id":"https://openalex.org/keywords/mouse-model-of-infection","display_name":"mouse infection model","score":0.6230000257492065},{"id":"https://openalex.org/keywords/nonlinear-mixed-effects-modelling","display_name":"nonlinear mixed-effects modelling","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.8679999709129333},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.8281999826431274},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.755299985408783},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.694100022315979},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.54339998960495},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5123000144958496},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5120000243186951},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4569000005722046},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.45170000195503235},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4122999906539917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4036000072956085},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38109999895095825},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.3732999861240387},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3118000030517578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3003000020980835},{"id":"https://openalex.org/C2778117688","wikidata":"https://www.wikidata.org/wiki/Q264024","display_name":"Animal model","level":2,"score":0.2935999929904938},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.28610000014305115},{"id":"https://openalex.org/C3019389975","wikidata":"https://www.wikidata.org/wiki/Q60740533","display_name":"Log reduction","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.2703999876976013},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2651999890804291}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.10.750598","doi":"https://doi.org/10.64898/2026.09.10.750598","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.10.750598","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/15/2026.09.10.750598.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.10.750598","doi":"https://doi.org/10.64898/2026.09.10.750598","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.10.750598","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/15/2026.09.10.750598.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3229258877","display_name":"S\u00e9quen\u00e7age du g\u00e9nome entier et intelligence artificielle pour carat\u00e9riser et diagnostiquer la r\u00e9sistance aux antibiotiques et la capacit\u00e9 d'\u00e9chapper au traitement","funder_award_id":"ANR-20-PAMR-0010","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G5296751580","display_name":null,"funder_award_id":"ANR-20","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213277486.pdf","grobid_xml":"https://content.openalex.org/works/W7213277486.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W105671925","https://openalex.org/W627913863","https://openalex.org/W1998449630","https://openalex.org/W2005824807","https://openalex.org/W2024427959","https://openalex.org/W2101409256","https://openalex.org/W2106050397","https://openalex.org/W2116306112","https://openalex.org/W2137928929","https://openalex.org/W2139396458","https://openalex.org/W2152118216","https://openalex.org/W2173560000","https://openalex.org/W2550207834","https://openalex.org/W2756286376","https://openalex.org/W2903934277","https://openalex.org/W4386771515","https://openalex.org/W4392709006","https://openalex.org/W4409411395","https://openalex.org/W4413872377","https://openalex.org/W6892667879","https://openalex.org/W6911264654"],"related_works":["https://openalex.org/W2071627581","https://openalex.org/W4404451972","https://openalex.org/W1998449630","https://openalex.org/W2173560000","https://openalex.org/W2301193798","https://openalex.org/W4391577241","https://openalex.org/W4289315365","https://openalex.org/W2137928929","https://openalex.org/W2137326453","https://openalex.org/W2191399122"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Optimal":[2],"antibiotic":[3],"dosing":[4,283],"regimens":[5],"depend":[6],"on":[7,27,52,89,258],"the":[8,117,138,159,246,266],"pharmacokinetic/pharmacodynamic":[9],"(PK/PD)":[10],"index":[11,157],"that":[12,235,276],"best":[13],"predicts":[14],"antibacterial":[15],"efficacy.":[16],"PK/PD":[17,141,156,248,272],"targets":[18,250],"are":[19,186],"traditionally":[20],"determined":[21],"using":[22,61,74,149,191],"murine":[23,107,192],"infection":[24,194,253],"models":[25],"based":[26],"a":[28,53,62,202,229,259],"limited":[29],"number":[30],"of":[31,56,93,231,262,268],"bacterial":[32,124,132],"isolates.":[33],"Objective":[34],"This":[35],"study":[36],"aimed":[37],"to":[38,120,200,281],"investigate":[39],"whether":[40],"animal":[41,252],"experiments":[42,50,86,239,257],"could":[43],"be":[44],"replaced":[45],"by":[46],"in":[47,122,236,271],"vitro":[48,84,237],"time-kill":[49,85,238],"performed":[51,88],"large":[54,260],"collection":[55],"clinical":[57,91,263,282],"isolates":[58,92,264],"and":[59,81,114,137,145,179,215,219],"analyzed":[60],"modelling":[63,243],"approach":[64],"accounting":[65],"for":[66],"inter-strain":[67,212,269],"variability.":[68],"The":[69,128,155,196],"proposed":[70],"framework":[71],"was":[72,101,110,168,206],"evaluated":[73],"meropenem":[75,163,224],"against":[76,225],"Pseudomonas":[77],"aeruginosa":[78,95,227],".":[79,96],"Materials":[80],"Methods":[82],"In":[83],"were":[87,147],"66":[90],"P.":[94,226],"A":[97,106],"population":[98],"pharmacodynamic":[99,118],"model":[100,109,119],"developed":[102],"from":[103,112],"experimental":[104],"data.":[105],"pharmacokinetic":[108],"reproduced":[111],"literature":[113],"combined":[115,240],"with":[116,162,174,188,210,241],"simulate":[121],"vivo":[123],"burden":[125],"over":[126],"time.":[127],"relationships":[129],"between":[130],"simulated":[131],"counts":[133],"at":[134,165,208],"24":[135,166],"h":[136,167],"three":[139],"main":[140],"indices":[142],"(fCmax/MIC,":[143],"fAUC/MIC":[144,175],"%fT>MIC)":[146],"characterized":[148],"nonlinear":[150],"mixed-effects":[151],"Imax":[152],"models.":[153,195,254],"Results":[154],"showing":[158],"strongest":[160],"correlation":[161],"efficacy":[164,249],"%fT>MIC":[169,197],"(R\u00b2":[170,176,181],"=":[171,177,182],"0.989),":[172],"compared":[173],"0.373)":[178],"fCmax/MIC":[180],"0.284).":[183],"These":[184],"findings":[185],"consistent":[187],"previous":[189],"studies":[190],"thigh":[193],"target":[198],"required":[199],"achieve":[201],"2-log":[203],"CFU":[204],"reduction":[205],"estimated":[207],"44%,":[209],"substantial":[211],"variability":[213,270],"(10th":[214],"90th":[216],"percentiles:":[217],"27%":[218],"71%,":[220],"respectively).":[221],"Conclusions":[222],"Using":[223],"as":[228,251],"proof":[230],"concept,":[232],"we":[233],"demonstrate":[234],"pharmacometric":[242],"can":[244],"identify":[245],"same":[247],"Moreover,":[255],"performing":[256],"panel":[261],"enables":[265],"quantification":[267],"targets,":[273],"providing":[274],"information":[275],"may":[277],"improve":[278],"their":[279],"translation":[280],"optimization.":[284]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-16T00:00:00"}